Halozyme Therapeutics shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.5M | 35k | 73.34 |
| 2025-06-30 | $1.5M | 28k | 52.02 |
| 2025-03-31 | $1.0M | 16k | 63.81 |
| 2024-06-30 | $1.6M | 31k | 52.36 |
| 2023-12-31 | $1.2M | 32k | 36.96 |
| 2023-06-30 | $1.7M | 46k | 36.07 |
| 2023-03-31 | $1.4M | 38k | 38.19 |
| 2022-12-31 | $432k | 7.6k | 56.90 |
| 2022-09-30 | $637k | 16k | 39.57 |
| 2022-06-30 | $876k | 20k | 44.02 |
| 2021-06-30 | $354k | 7.8k | 45.38 |
| 2021-03-31 | $353k | 8.5k | 41.70 |
| 2017-12-31 | $462k | 23k | 20.26 |
| 2016-06-30 | $97k | 11k | 8.66 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management